SEC Form 4 · accession 0001159036-15-000031
HALOZYME THERAPEUTICS, INC. · HALO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David A Ramsay
Officer — VP and Chief Financial Officer
Period of report
Feb 2, 2015
Accepted (ET)
Feb 4, 2015 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001159036
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 2, 2015 | M | 3,125 | $0.00 | A | 357,679 | D | |
| Common Stock | Feb 4, 2015 | M | 2,213 | $0.00 | A | 359,892 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Award | $0.00 | Feb 2, 2015 | M | 3,125 | D | Feb 2, 2014 | Feb 2, 2022 | Common Stock | 3,125 | 3,125 | D |
| Restricted Stock Award | $0.00 | Feb 4, 2015 | M | 2,213 | D | Feb 4, 2014 | Feb 4, 2023 | Common Stock | 2,213 | 4,424 | D |